Role of quinine in life-threatening Babesia divergens infection successfully treated with clindamycin

  • C. Corpelet
  • P. Vacher
  • F. Coudore
  • H. Laurichesse
  • N. Conort
  • B. Souweine
Brief Report

References

  1. 1.
    Beattie JF, Michelson ML, Holman PJ (2002) Acute babesiosis caused by Babesia divergens in a resident of Kentucky. N Engl J Med 347:697–698Google Scholar
  2. 2.
    Homer MJ, Aguilar-Delfin I, Telford SR VIII, Krause PJ, Persing DH (2000) Babesiosis. Clin Microbiol Rev 13:451–469CrossRefPubMedGoogle Scholar
  3. 3.
    Brasseur P, Lecoublet S, Kapel N, Favennec L, Ballet JJ (1996) Quinine in the treatment of Babesia divergens infections in humans. Eur J Clin Microbiol Infect Dis 15:840–841Google Scholar
  4. 4.
    Brasseur P, Lecoublet S, Kapel N, Favennec L, Ballet JJ (1998) In vitro evaluation of drug susceptibilities of Babesia divergens isolates. Antimicrob Agents Chemother 42:818–820Google Scholar
  5. 5.
    Denes E, Rogez JP, Dardé ML, Weinbreck P (1999) Management of Babesia divergens babesiosis without a complete course of quinine treatment. Eur J Clin Microbiol Infect Dis 18:672–673Google Scholar
  6. 6.
    Bateman DN, Blain PG, Woodhouse KW, Rawlins MD, Dyson H, Heyworth R, Prescott LF, Proudfoot AT (1985) Pharmakocinetics and clinical toxicity of quinine overdosage: lack of efficacy of techniques intended to enhance elimination. Quarterly J Med 54:125–131Google Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • C. Corpelet
    • 1
  • P. Vacher
    • 2
  • F. Coudore
    • 1
  • H. Laurichesse
    • 2
  • N. Conort
    • 3
  • B. Souweine
    • 2
  1. 1.Department of PharmacologyCHU Gabriel MontpiedClermont-Ferrand Cedex 1France
  2. 2.Department of Medical Intensive Care UnitCHU Gabriel MontpiedClermont-Ferrand Cedex 1France
  3. 3.Department of HaematologyCHR NeversNeversFrance

Personalised recommendations